<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03308331</url>
  </required_header>
  <id_info>
    <org_study_id>HP-00075780</org_study_id>
    <nct_id>NCT03308331</nct_id>
  </id_info>
  <brief_title>HIV-1 and Brain Interaction on Smoking Comorbidity</brief_title>
  <official_title>HIV-1 and Brain Interaction on Smoking Comorbidity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Maryland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Maryland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      People living with HIV-1 have high rates of cigarette smoking, which may be related to
      nicotinic interaction with HIV-1 infection and brain function levels. The proposed project
      aims to understand these pathways using translational brain imaging and HIV-1 reactivation
      studies. The study proposes a targeted nicotine-brain investigation of the nicotinic effects
      in HIV-1 infection from cellular to brain circuitry levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Smoking remains the leading cause of preventable morbidity and mortality in the United
      States. The alarmingly high smoking rates and unsatisfactory performance of standard smoking
      cessation efforts in people living with HIV/AIDS (PLWH) interfere with the overall progress
      in the treatment of HIV-1 infection. Our understanding of nicotine addiction mechanisms in
      PLWH, and how they are related to and interact with HIV-1 neuropathology, is limited and thus
      hindering the development of more effective, targeted treatments. The study will directly
      address neurological complication of this HIV-associated comorbidity at the brain circuitry
      level using state-of-the-art imaging tools and methods.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2018</start_date>
  <completion_date type="Anticipated">October 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional and structural connectivity using magnetic resonance imaging (MRI)</measure>
    <time_frame>one day</time_frame>
    <description>Resting functional MRI and diffusion imaging MRI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HIV-1 reactivation</measure>
    <time_frame>one day</time_frame>
    <description>HIV-1 viral protein p24 expression</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Smoking</condition>
  <arm_group>
    <arm_group_label>HIV-1 smokers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV-1 nonsmokers</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy control smokers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy control nonsmokers</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV-1 nonsmokers using nicotine patch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV-1 nonsmokers using placebo patch</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy control nonsmokers using nicotine patch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy control nonsmokers using placebo patch</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Tobacco smoking and nicotine patch</intervention_name>
    <description>Tobacco smoking at each participant's regular cigarette. Over-the-counter nicotine patch use</description>
    <arm_group_label>HIV-1 smokers</arm_group_label>
    <arm_group_label>Healthy control smokers</arm_group_label>
    <arm_group_label>HIV-1 nonsmokers using nicotine patch</arm_group_label>
    <arm_group_label>Healthy control nonsmokers using nicotine patch</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects between ages 18-60 in good health

          2. Ability to give written informed consent

          3. For people living with HIV: should be diagnosed with HIV two years or more and on ART
             two years or more

          4. For people living with HIV: should have achieved virologic suppression (defined as
             viral loads of â‰¤ 200 copies/ml), and without current signs of reactivation

        Exclusion Criteria:

          1. Inability to sign informed consent

          2. Unable to undergo MRI scanning due to metallic devices or objects (cardiac pacemaker
             or neurostimulator, some artificial joints, metal pins, surgical clips or other
             implanted metal parts) or claustrophobic to the scanner

          3. Any major medical illnesses to include, but not limited to, uncontrolled high blood
             pressure or high blood sugar, cardiovascular disease, asthma, peripheral vascular
             diseases, coagulopathies, history of superficial or deep vein thrombosis as per
             medical history

          4. Current substance-induced psychiatric disorders

          5. Significant alcohol or other drug use, other than nicotine dependence or marijuana use

          6. Gross structural abnormalities and/or have a history of syncope

          7. Positive urine pregnancy tests

          8. Any neurological illnesses to include, but not limited to, seizure disorders, multiple
             sclerosis, movement disorders, or history of head trauma, CVA, CNS tumor,

          9. For people living with HIV: having AIDS or non-AIDS-defining cancer or active CNS and
             other opportunistic disease

         10. For people living with HIV: on active treatment of hepatitis C virus (HCV)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dawn Detamore</last_name>
    <phone>4104026820</phone>
    <email>ddetamor@mprc.umaryland.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elliot Hong, MD</last_name>
    <phone>4104026828</phone>
    <email>ehong@mprc.umaryland.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Maryland School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21228</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dawn Detamore</last_name>
      <phone>410-402-6820</phone>
      <email>ddetamor@mprc.umaryland.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2017</study_first_submitted>
  <study_first_submitted_qc>October 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2017</study_first_posted>
  <last_update_submitted>January 18, 2018</last_update_submitted>
  <last_update_submitted_qc>January 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Maryland</investigator_affiliation>
    <investigator_full_name>L. Elliot Hong</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>nicotine</keyword>
  <keyword>brain</keyword>
  <keyword>smoking</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

